Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.50
Bid: 30.00
Ask: 31.00
Change: -3.00 (-8.96%)
Spread: 1.00 (3.333%)
Open: 37.50
High: 38.00
Low: 30.50
Prev. Close: 33.50
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Mitchells & Butlers Down Amid Raise Plan

Thu, 07th Jan 2021 10:51

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.

----------

FTSE 100 - WINNERS

----------

J Sainsbury, up 3.8%. The grocer's like-for-like sales in the nine weeks to January 2 - so including the key festive period - were up 9.3% year-on-year. For the whole of its third-quarter, like-for-like sales, excluding fuel, climbed 8.6%. Including fuel, like-for-like sales were up a more modest 3.2%.

----------

FTSE 100 - LOSERS

----------

Experian, down 2.4%. The stock went ex-dividend, meaning new buyers no longer qualify for the latest payout.

----------

FTSE 250 - LOSERS

----------

Trainline, down 7.8%. Launched an offering of GBP150 million of senior unsecured convertible bonds due 2026. The train booking platform operator in UK said the net proceeds of the five-year bonds will "provide additional liquidity, protecting the business further in an extended Covid downturn".

----------

Mitchells & Butlers, down 7.0%. Reports sharp 67% sales fall for 14 weeks to January 2 and adds that it is mulling an equity raise.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Sareum Holdings, up 10%. The Cambridge-based drug developer said the US Patent Office approved its patent application for an invention associated with its SDC-1802 TYK2/JAK1 kinase inhibitor programme

----------

James Fisher & Sons, up 7.9%. The marine services provider saw improved trading in its fourth quarter, so now expects 2020 underlying profit to be at the upper end of its guided range.

----------

Synectics, up 4.9%. The Sheffield, England-based provider of security systems has successfully deployed the first phase of its operational management system for German railway operator S-Bahn in Berlin.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Ormonde Mining, down 29%. Adjourns annual general meeting scheduled for Thursday. The Spain-focused natural resources firm says this is so it can continue talks with its largest shareholder over motions six to eight, concerning its share capital and ability to make market purchases.

----------

Joules Group, down 6.1%. The retailer said sales in the seven months trading period to January 3 were better than expected, though in-store sales in the seven weeks to January 3 plunged 58%.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
19 Apr 2024 12:16

IN BRIEF: Sareum falls as issues shares to RiverFort Global

Sareum Holdings PLC - Cambridge, England-based pharmaceutical company - Issues 3.0 million new shares in the company to RiverFort Global Opportunities PCC Ltd. Issue is in line with facility announced in August. Says facility has an outstanding balance of GBP220,000.

Read more
4 Apr 2024 17:24

TRADING UPDATES: Northcoders launches bootcamp; Schroder invests

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
2 Apr 2024 17:35

TRADING UPDATES: Sareum ups retail offer; SThree nabs former ITV exec

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
28 Mar 2024 13:44

EARNINGS AND TRADING: Northamber loss widens; Ethernity contract boost

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
15 Mar 2024 13:11

Sareum allowed European patent for primary kinase inhibitor asset

(Sharecast News) - Biotechnology company Sareum announced on Friday that the European Patent Office had issued a notice of allowance for a patent concerning SDC‐1801, its primary TYK2/JAK1 kinase inhibitor currently undergoing clinical trials in Australia.

Read more
15 Mar 2024 12:46

Sareum Holdings touts new patent allowance for autoimmune therapy

(Alliance News) - Sareum Holdings PLC on Friday celebrated a new patent allowance for SDC-1801, which is a therapy designed to treat a range of autoimmune diseases.

Read more
12 Mar 2024 15:23

Sareum shares slump on widened loss and funding talks

(Alliance News) - Sareum Holdings PLC share fell on Tuesday, after it said it expects to report a widened interim loss.

Read more
15 Feb 2024 13:22

Sareum reports positive progress in psoriasis programme

(Sharecast News) - Sareum announced significant milestones in its phase 1a clinical trial for SDC-1801, its lead programme aimed at addressing autoimmune diseases such as psoriasis, on Thursday.

Read more
15 Feb 2024 11:20

Sareum hails safety profile for SDC-1801 after phase 1 trial

(Alliance News) - Sareum Holdings PLC on Thursday said SDC-1801 has the potential to achieve therapeutically effective dose levels with no serious adverse events, following a phase 1 trial.

Read more
15 Feb 2024 10:52

AIM WINNERS & LOSERS: DSW warns on earnings amid tepid M&A markets

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
2 Jan 2024 13:54

Sareum shares jump on cancer drug licensing deal

(Sharecast News) - Shares in AIM-listed biotech group Sareum jumped by a fifth on Tuesday after its co-development partner for cancer treatment SRA737 signed a commercialisation licence agreement with a US biopharma company.

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 10:05

AIM WINNERS & LOSERS: LungLife AI soars on test; Plexus falls on deal

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
2 Jan 2024 09:31

Sareum soars as partner agrees SRA737 licence with US biopharma firm

(Alliance News) - Sareum Holdings PLC shares surged on Tuesday, after it said its co-development partner CRT Pioneer Fund entered into a development and commercialisation licence for SRA737 with an unnamed US biopharmaceutical company.

Read more
14 Dec 2023 20:20

EARNINGS AND TRADING: CleanTech raises GBP520,000 in open offer

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.